APA (7th ed.) Citation

K, F., WP, H., N, B., H, P., P, V., A, E., . . . UK, B. (2024). Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development. Vaccines, 12(9), . https://doi.org/10.3390/vaccines12090974

Chicago Style (17th ed.) Citation

K, Feemster, Hausdorff WP, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A, Burton RL, Nahm MH, and Buchwald UK. "Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development." Vaccines 12, no. 9 (2024). https://doi.org/10.3390/vaccines12090974.

MLA (9th ed.) Citation

K, Feemster, et al. "Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development." Vaccines, vol. 12, no. 9, 2024, https://doi.org/10.3390/vaccines12090974.